AAAAAA

   
Results: 1-4 |
Results: 4
APPLICATION OF PHARMACODYNAMIC MODELING FOR DESIGNING TIME-VARIANT DOSING REGIMENS TO OVERCOME NITROGLYCERIN TOLERANCE IN EXPERIMENTAL HEART-FAILURE
Authors: BAUER JA BALTHASAR JP FUNG HL
Citation: Ja. Bauer et al., APPLICATION OF PHARMACODYNAMIC MODELING FOR DESIGNING TIME-VARIANT DOSING REGIMENS TO OVERCOME NITROGLYCERIN TOLERANCE IN EXPERIMENTAL HEART-FAILURE, Pharmaceutical research, 14(9), 1997, pp. 1140-1145
PHARMACOKINETIC AND PHARMACODYNAMIC OPTIMIZATION OF INTRAPERITONEAL CHEMOTHERAPY
Authors: BALTHASAR JP FUNG HL
Citation: Jp. Balthasar et Hl. Fung, PHARMACOKINETIC AND PHARMACODYNAMIC OPTIMIZATION OF INTRAPERITONEAL CHEMOTHERAPY, Life sciences, 58(7), 1996, pp. 535-543
INVERSE TARGETING OF PERITONEAL TUMORS - SELECTIVE ALTERATION OF THE DISPOSITION OF METHOTREXATE THROUGH THE USE OF ANTIMETHOTREXATE ANTIBODIES AND ANTIBODY FRAGMENTS
Authors: BALTHASAR JP FUNG HL
Citation: Jp. Balthasar et Hl. Fung, INVERSE TARGETING OF PERITONEAL TUMORS - SELECTIVE ALTERATION OF THE DISPOSITION OF METHOTREXATE THROUGH THE USE OF ANTIMETHOTREXATE ANTIBODIES AND ANTIBODY FRAGMENTS, Journal of pharmaceutical sciences, 85(10), 1996, pp. 1035-1043
HIGH-AFFINITY RABBIT ANTIBODIES DIRECTED AGAINST METHOTREXATE - PRODUCTION, PURIFICATION, CHARACTERIZATION, AND PHARMACOKINETICS IN THE RAT
Authors: BALTHASAR JP FUNG HL
Citation: Jp. Balthasar et Hl. Fung, HIGH-AFFINITY RABBIT ANTIBODIES DIRECTED AGAINST METHOTREXATE - PRODUCTION, PURIFICATION, CHARACTERIZATION, AND PHARMACOKINETICS IN THE RAT, Journal of pharmaceutical sciences, 84(1), 1995, pp. 2-6
Risultati: 1-4 |